AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: ZHAN S HELMAN LJ
Citation: S. Zhan et Lj. Helman, GLIMPSING THE CAUSE OF RHABDOMYOSARCOMA, Nature medicine, 4(5), 1998, pp. 559-560

Authors: ZHANG LJ ZHAN QM ZHAN SL KASHANCHI F FORNACE AJ SETH P HELMAN LJ
Citation: Lj. Zhang et al., P53 REGULATES HUMAN INSULIN-LIKE-GROWTH-FACTOR-II GENE-EXPRESSION THROUGH ACTIVE P4 PROMOTER IN RHABDOMYOSARCOMA CELLS, DNA and cell biology, 17(2), 1998, pp. 125-131

Authors: ZHANG LJ ZHAN SL NAVID F LI QD CHOI YH KIM M SETH P HELMAN LJ
Citation: Lj. Zhang et al., AP-2 MAY CONTRIBUTE TO IGF-II OVEREXPRESSION IN RHABDOMYOSARCOMA, Oncogene, 17(10), 1998, pp. 1261-1270

Authors: KALEBIC T BLAKESLEY V SLADE C PLASSCHAERT S LEROITH D HELMAN LJ
Citation: T. Kalebic et al., EXPRESSION OF A KINASE-DEFICIENT IGF-I-R SUPPRESSES TUMORIGENICITY OFRHABDOMYOSARCOMA CELLS CONSTITUTIVELY EXPRESSING A WILD-TYPE IGF-I-R, International journal of cancer, 76(2), 1998, pp. 223-227

Authors: ZHAN SL ZHAN SX ZHANG LJ VAN M YOUNG C HELMAN LJ
Citation: Sl. Zhan et al., BIALLELIC EXPRESSION OF ALL 4 IGF-II PROMOTERS AND ITS ASSOCIATION WITH INCREASED METHYLATION OF H19 GENE IN HUMAN BRAIN, Brain research, 792(2), 1998, pp. 283-290

Authors: BLAKESLEY VA STANNARD BS KALEBIC T HELMAN LJ LEROITH D
Citation: Va. Blakesley et al., ROLE OF THE IGF-I RECEPTOR IN MUTAGENESIS AND TUMOR PROMOTION, Journal of Endocrinology, 152(3), 1997, pp. 339-344

Authors: TORETSKY JA KALEBIC T BLAKESLEY V LEROITH D HELMAN LJ
Citation: Ja. Toretsky et al., THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR IS REQUIRED FOR EWS FLI-1 TRANSFORMATION OF FIBROBLASTS/, The Journal of biological chemistry, 272(49), 1997, pp. 30822-30827

Authors: GOLETZ TJ ZHAN S PENDLETON CD HELMAN LJ BERZOFSKY JA
Citation: Tj. Goletz et al., GENERATION OF CYTOTOXIC T-CELLS AGAINST TUMOR-SPECIFIC TRANSLOCATIONS- POTENTIAL ANTICANCER VACCINES FOR EWINGS-SARCOMA AND ALVEOLAR RHABDOMYOSARCOMA, The FASEB journal, 10(6), 1996, pp. 2521-2521

Authors: KALEBIC T JUDDE JG VELEZYANGUAS M KNUTSEN T HELMAN LJ
Citation: T. Kalebic et al., METASTATIC HUMAN RHABDOMYOSARCOMA - MOLECULAR, CELLULAR AND CYTOGENETIC ANALYSIS OF A NOVEL CELLULAR-MODEL, Invasion & metastasis, 16(2), 1996, pp. 83-96

Authors: VELEZYANGUAS MC KALEBIC T MAGGI M KAPPEL CC LETTERIO J USKOKOVIC M HELMAN LJ
Citation: Mc. Velezyanguas et al., ROXY-16-ENE-23-YNE-26,27-HEXAFLUOROCHOLECALCIFEROL (RO24-5531) MODULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 AND INDUCTION OF DIFFERENTIATION AND GROWTH ARREST IN A HUMAN OSTEOSARCOMA CELL-LINE, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 93-99

Authors: KALEBIC T TSOKOS M HELMAN LJ
Citation: T. Kalebic et al., SUPPRESSION OF RHABDOMYOSARCOMA GROWTH BY FUMAGILLIN ANALOG TNP-470, International journal of cancer, 68(5), 1996, pp. 596-599

Authors: BLAKESLEY VA KALEBIC T HELMAN LJ STANNARD B FARIA TN ROBERTS CT LEROITH D
Citation: Va. Blakesley et al., TUMORIGENIC AND MITOGENIC CAPACITIES ARE REDUCED IN TRANSFECTED FIBROBLASTS EXPRESSING MUTANT INSULIN-LIKE GROWTH-FACTOR (IGF)-I RECEPTORS - THE ROLE OF TYROSINE RESIDUE-1250, RESIDUE-1251, AND RESIDUE-1316 INTHE CARBOXY-TERMINUS OF THE IGF-I RECEPTOR, Endocrinology, 137(2), 1996, pp. 410-417

Authors: ZHANG LJ KASHANCHI F ZHAN QM ZHAN SL BRADY JN FORNACE AJ SETH P HELMAN LJ
Citation: Lj. Zhang et al., REGULATION OF INSULIN-LIKE-GROWTH-FACTOR-II P3 PROMOTER BY P53 - A POTENTIAL MECHANISM FOR TUMORIGENESIS, Cancer research, 56(6), 1996, pp. 1367-1373

Authors: MINNITI CP LUAN D OGRADY C ROSENFELD RG OH Y HELMAN LJ
Citation: Cp. Minniti et al., INSULIN-LIKE GROWTH-FACTOR-II OVEREXPRESSION IN MYOBLASTS INDUCES PHENOTYPIC CHANGES TYPICAL OF THE MALIGNANT PHENOTYPE, Cell growth & differentiation, 6(3), 1995, pp. 263-269

Authors: GAETANO C MANNI I BOSSI G PIAGGIO G SODDU S FARINA A HELMAN LJ SACCHI A
Citation: C. Gaetano et al., RETINOIC ACID AND CAMP DIFFERENTIALLY REGULATE HUMAN CHROMOGRANIN-A PROMOTER ACTIVITY DURING DIFFERENTIATION OF NEUROBLASTOMA-CELLS, European journal of cancer, 31A(4), 1995, pp. 447-452

Authors: ZHAN SL SHAPIRO DN HELMAN LJ
Citation: Sl. Zhan et al., LOSS OF IMPRINTING OF IGF2 IN EWINGS-SARCOMA, Oncogene, 11(12), 1995, pp. 2503-2507

Authors: ZHAN SL SHAPIRO D ZHAN SX ZHANG LJ HIRSCHFELD S ELASSAL J HELMAN LJ
Citation: Sl. Zhan et al., CONCORDANT LOSS OF IMPRINTING OF THE HUMAN-INSULIN-LIKE-GROWTH-FACTOR-II GENE PROMOTERS IN CANCER, The Journal of biological chemistry, 270(47), 1995, pp. 27983-27986

Authors: NOLAN EM HELMAN LJ BURTON DW DEFTOS LJ
Citation: Em. Nolan et al., CLONING OF THE HUMAN CHROMOGRANIN-A PROMOTER AND IDENTIFICATION OF A SEQUENCE THAT POSSESSES ENHANCER-LIKE ACTIVITY, Endocrine, 2(10), 1994, pp. 891-897

Authors: ZHAN SL SHAPIRO DN HELMAN LJ
Citation: Sl. Zhan et al., ACTIVATION OF AN IMPRINTED ALLELE OF THE INSULIN-LIKE GROWTH-FACTOR-II GENE IMPLICATED IN RHABDOMYOSARCOMA, The Journal of clinical investigation, 94(1), 1994, pp. 445-448

Authors: LUJAN HD MOWATT MR HELMAN LJ NASH TE
Citation: Hd. Lujan et al., INSULIN-LIKE GROWTH-FACTORS STIMULATE GROWTH AND L-CYSTEINE UPTAKE BYTHE INTESTINAL PARASITE GIARDIA-LAMBLIA, The Journal of biological chemistry, 269(18), 1994, pp. 13069-13072

Authors: KALEBIC T TSOKOS M HELMAN LJ
Citation: T. Kalebic et al., IN-VIVO TREATMENT WITH ANTIBODY AGAINST IGF-1 RECEPTOR SUPPRESSES GROWTH OF HUMAN RHABDOMYOSARCOMA AND DOWN-REGULATES P34(CDC2), Cancer research, 54(21), 1994, pp. 5531-5534

Authors: KALEBIC T TSOKOS M HELMAN LJ
Citation: T. Kalebic et al., IN-VIVO TREATMENT WITH ANTIBODY AGAINST IGF-1 RECEPTOR SUPPRESSES GROWTH OF HUMAN RHABDOMYOSARCOMA AND DOWN-REGULATES P34(CDC2), Cancer research, 54(21), 1994, pp. 5531-5534

Authors: KAPPEL CC VELEZYANGUAS MC HIRSCHFELD S HELMAN LJ
Citation: Cc. Kappel et al., HUMAN OSTEOSARCOMA CELL-LINES ARE DEPENDENT ON INSULIN-LIKE GROWTH-FACTOR-I FOR IN-VITRO GROWTH, Cancer research, 54(10), 1994, pp. 2803-2807

Authors: WEXLER LH HELMAN LJ
Citation: Lh. Wexler et Lj. Helman, PEDIATRIC SOFT-TISSUE SARCOMAS, Ca, 44(4), 1994, pp. 211-247

Authors: MINNITI CP TSOKOS M NEWTON WA HELMAN LJ
Citation: Cp. Minniti et al., SPECIFIC EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-II IN RHABDOMYOSARCOMA TUMOR-CELLS, American journal of clinical pathology, 101(2), 1994, pp. 198-203
Risultati: 1-25 | 26-28